Poster Session II: Ongoing Trials

By  

Cerebrovascular Diseases, Vol. 9, Iss. 1, 1999-03 ,pp. : 105-109

Karger

Access to resources Recommend Favorite

A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus

By Tanaka Yoshiya   Yamamoto Kazuhiko   Takeuchi Tsutomu   Nishimoto Norihiro   Miyasaka Nobuyuki   Sumida Takayuki   Shima Yoshihito   Takada Kazuki   Matsumoto Isao   Saito Kazuyoshi   Koike Takao  

Modern Rheumatology, Vol. 17, Iss. 3, 2007-06 ,pp. : 191-197

Springer Publishing Company

Access to resources Recommend Favorite

Current Status and Ongoing Development of Reversing Agents for Novel Oral Anticoagulants (NOACs)

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 8, Iss. 1, 2013-04 ,pp. : 2-9

Bentham Science Publishers

Access to resources Recommend Favorite

Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil

By  

Liver Cancer, Vol. 4, Iss. 4, 2015-0 ,pp. : 263-273

Karger

Access to resources Recommend Favorite

Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement - results from Phase II studies

By Eriksson B.I.   Ogren M.   Eriksson U.G.   Kalebo P.   Ahnfelt L.   Bjorkstrom S.   Sjostedt .   Folestad A.   Arfwidsson A.-C.   Elvander C.S.   Frison L.  

Thrombosis Research, Vol. 105, Iss. 5, 2002-03 ,pp. : 371-378

Elsevier

Access to resources Recommend Favorite